Despite commitments by heavyweights such as Blackstone and Apollo Global Management to deploy hundreds of billions across Europe over the coming decade, the near-term outlook for private equity buyouts remains uncertain, according to a report by Bloomberg.
After a sluggish M&A environment, the last quarter saw a modest uptick in headline corporate deals and some easing of tariff-related anxieties in the US. Yet, private equity players remain cautious.
Market insiders, speaking on condition of anonymity, highlighted that soaring valuations in public equities are inflating private asset prices, complicating deal negotiations and prolonging sales processes.
While stock markets have recently rallied to record highs – fostering hopes of a strong year for dealmaking – private equity transactions tell a different story. Bloomberg’s preliminary data shows buyout deal activity declined by over 20% year-on-year in Q2. Firms remain hesitant buyers, with exceptions like KKR standing out amid the wider reluctance.
A significant hurdle is the disconnect between elevated acquisition prices and rising debt costs used to finance buyouts. Recent examples illustrate the challenges: Platinum Equity paused the sale of its Spanish waste management platform Urbaser SA after failing to agree on terms with interested parties including Blackstone and Abu Dhabi’s ADQ. Instead, Urbaser opted for a €2.3bn debt raise to support a dividend distribution and refinance debt, reflecting a trend among sponsors seeking liquidity for investors amid limited exit options.
Valuation gaps between sellers’ expectations and buyers’ willingness to pay remain a persistent drag on deal flow. Brookfield Asset Management withdrew its bid for Spanish pharma Grifols SA last year due to similar disagreements, though talks reportedly resumed recently.
Public market volatility has also impacted IPO exits for PE-backed firms in Europe. Apollo-backed Autodoc SE postponed its German IPO last week, followed by medical technology firm Brainlab, underscoring the fragile sentiment.
Private equity valuation typically references comparable listed peers, but several market participants note skepticism over public markets’ disconnect from underlying fundamentals. US market rebounds have been largely retail-driven post-tariff relief, while European equities have benefited from reduced US political risk.
Cautious buy-side behavior is further compounded by an evolving capital structure landscape. With lenders tightening, private equity firms increasingly rely on greater equity contributions, shifting more risk onto their own balance sheets compared to the heavily leveraged deals typical of previous cycles.
Still, the vast dry powder and announced capital commitments provide a silver lining. Blackstone’s CEO Steve Schwarzman recently stated plans to invest up to $500bn in Europe over the next decade, while Apollo’s president Jim Zelter outlined ambitions to deploy $100bn in Germany alone, aiming to fuel a “renaissance” in European private equity.
Innovative financing structures may also ease deal-making hurdles. Urbaser’s recent €1bn debt raise includes ‘portable’ debt provisions, allowing the financing to remain post-sale, potentially enhancing asset appeal by guaranteeing stable funding to future owners.
While deal flow remains constrained today, private equity sellers and buyers alike hope the incoming capital and a potential macroeconomic thaw will unlock market momentum, improve fund performance, and revive fundraising – setting the stage for a more active M&A environment ahead.
